NCT04560049

Brief Summary

Pilonidal sinus is a disease that affects the young population. Wound healing is a problem after surgical interventions Especially wound healing brings minimally invasive interventions to the fore. In this study we will administer two types of irritating agent for pilonidal sinus disesase. One of them is phenol and second one is silver nitrate solution. And not routinely used for pilonidal sinus disease. The data about availeble in pubmed and google scholar is limited focused on silver nitrate The goal of the study is to compare the silver nitrate and phenol application

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Jun 2020

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 3, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 9, 2020

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 23, 2020

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2023

Completed
Last Updated

December 6, 2024

Status Verified

December 1, 2024

Enrollment Period

2 years

First QC Date

September 9, 2020

Last Update Submit

December 5, 2024

Conditions

Keywords

Pilonidal SinusPhenolSilver Nitrate

Outcome Measures

Primary Outcomes (1)

  • Healing of the pilonidal sinus disease

    Closure of pit without pus and soiling on physical examination

    8 week

Secondary Outcomes (3)

  • Post-procedure Quality of life assessment

    3rd and 8th week after the procedure

  • Wound infection

    3rd and 8th week after the procedure

  • Visual analog scale as pain assessment

    3rd and 8th week after the procedure

Study Arms (2)

Phenolisation

EXPERIMENTAL

Surgical pit excision and phenolisation of sinus tract

Drug: Phenol

Silver Nitrate Irrigation

ACTIVE COMPARATOR

Surgical pit excision and silver nitrate irrigation of sinus tract

Drug: Silver Nitrate

Interventions

application of silver nitrate to sinus tract

Silver Nitrate Irrigation
PhenolDRUG

phenolisation of sinus tract

Phenolisation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 18 years old
  • Patients who applied to general surgery outpatient clinic for chronic sacrococcygeal pilonidal sinus
  • Patients with written informed voluntary consent forms.

You may not qualify if:

  • BMI \> 35 kg/m²
  • Recurrent cases
  • Active abscess formation
  • Patients with hydradenitis suppurativa and skin lesions in the perianal region
  • Patients with accompanying anal fistula, anal conduloma and perianal involvement of Crohn's disease
  • Immunosuppressive patients (HIV +, organ transplantation, patients receiving immunosuppressive therapy)
  • Complicated cases (have more than 3 orifice)
  • Patients with known allergic sensitivity to one of the silver nitrate, phenol, nitrofurazone and prilocaine substances

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Health Sciences Umraniye Education and Research Hospital

Istanbul, 34764, Turkey (Türkiye)

Location

Related Publications (6)

  • Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, Westlake L. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992 Jul 18;305(6846):160-4. doi: 10.1136/bmj.305.6846.160.

    PMID: 1285753BACKGROUND
  • Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, Dickersin K, Hrobjartsson A, Schulz KF, Parulekar WR, Krleza-Jeric K, Laupacis A, Moher D. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013 Jan 8;346:e7586. doi: 10.1136/bmj.e7586.

    PMID: 23303884BACKGROUND
  • Pronk AA, Smakman N, Furnee EJB. Short-term outcomes of radical excision vs. phenolisation of the sinus tract in primary sacrococcygeal pilonidal sinus disease: a randomized-controlled trial. Tech Coloproctol. 2019 Jul;23(7):665-673. doi: 10.1007/s10151-019-02030-w. Epub 2019 Jul 5.

  • Attaallah W, Tuney D, Gulluoglu BM, Ugurlu MU, Gunal O, Yegen C. Should we consider topical silver nitrate irrigation as a definitive nonsurgical treatment for perianal fistula? Dis Colon Rectum. 2014 Jul;57(7):882-7. doi: 10.1097/DCR.0000000000000143.

  • Kayaalp C, Aydin C. Review of phenol treatment in sacrococcygeal pilonidal disease. Tech Coloproctol. 2009 Sep;13(3):189-93. doi: 10.1007/s10151-009-0519-x. Epub 2009 Aug 5.

  • Emiroglu M, Karaali C, Esin H, Akpinar G, Aydin C. Treatment of pilonidal disease by phenol application. Turk J Surg. 2017 Mar 1;33(1):5-9. doi: 10.5152/UCD.2016.3532. eCollection 2017.

MeSH Terms

Conditions

Pilonidal Sinus

Interventions

Silver NitratePhenol

Condition Hierarchy (Ancestors)

CystsNeoplasms

Intervention Hierarchy (Ancestors)

NitratesNitric AcidNitrogen CompoundsInorganic ChemicalsSilver CompoundsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Study Officials

  • Hanife Ş Ülgür

    University of Health Sciences Umraniye Education and Research Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Doctor

Study Record Dates

First Submitted

September 9, 2020

First Posted

September 23, 2020

Study Start

June 3, 2020

Primary Completion

June 15, 2022

Study Completion

June 15, 2023

Last Updated

December 6, 2024

Record last verified: 2024-12

Locations